On September 14, 241 LEAD Coalition member organizations and allies wrote to Congress in support of the Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act (S. 1692/H.R.3354). The CHANGE Act will strengthen dementia detection and diagnosis, in turn catalyzing improved care, helping promote health equity, and accelerating science to prevent, effectively treat and eventually cure […]

Today, 237 LEAD Coalition member organizations and allies wrote to Congress urging that the FY 2022 appropriations bills include substantial increases in funding to strengthen the national response to Alzheimer’s disease and related forms of dementia. Read the Senate and House letters.